Literature DB >> 3214157

R plasmids in environmental Vibrio cholerae non-O1 strains.

C Amaro1, R Aznar, E Garay, E Alcaide.   

Abstract

The occurrence of drug resistance and its plasmid-mediated transferability was investigated in 140 environmental strains of Vibrio cholerae non-O1 and 6 strains of Vibrio cholerae, both O1 and non-O1, of clinical origin. Of the 146 strains tested, 93% were resistant to at least one drug and 74% were resistant to two or more antibiotics. The O1 strains were susceptible to all antibiotics used. A total of 26 of 28 selected resistant wild strains carried R plasmids that were transferable by intraspecific and intergeneric matings. The most common transmissible R factor determined resistance to ampicillin, amoxicillin, and sulfanilamide (30%), followed by resistance to ampicillin and amoxicillin (13%) and resistance to ampicillin, amoxicillin, phosphomycin, and sulfanilamide (9%). Comparison of the three methods of plasmid analysis showed that the method of Birnboim and Doly (Nucleic Acids Res. 7:1513-1523, 1979) without EDTA and lysozyme was optimal for isolation of both large and small plasmids in environmental V. cholerae strains. Most strains harbored more than one plasmid, and the molecular sizes ranged from 1.1 to 74.8 megadaltons. The plasmids of high molecular size (around 74 megadaltons) were responsible for the resistance pattern transferred and were maintained with high stability in the hosts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3214157      PMCID: PMC204371          DOI: 10.1128/aem.54.11.2771-2776.1988

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  20 in total

1.  Isolation of Non-O1 Vibrio cholerae Serovars from Oregon Coastal Environments.

Authors:  D L Tison; M Nishibuchi; R J Seidler; R J Siebeling
Journal:  Appl Environ Microbiol       Date:  1986-02       Impact factor: 4.792

Review 2.  Survival of, and genetic transfer by, genetically engineered bacteria in natural environments.

Authors:  G Stotzky; H Babich
Journal:  Adv Appl Microbiol       Date:  1986       Impact factor: 5.086

3.  Plasmid coding for transferable drug resistance in bacteria isolated from cultured rainbow trout.

Authors:  A E Toranzo; P Combarro; M L Lemos; J L Barja
Journal:  Appl Environ Microbiol       Date:  1984-10       Impact factor: 4.792

4.  R-plasmid transfer in Salmonella spp. isolated from wastewater and sewage-contaminated surface waters.

Authors:  E Alcaide; E Garay
Journal:  Appl Environ Microbiol       Date:  1984-08       Impact factor: 4.792

5.  Genetic, biochemical and molecular characterization of strains of Vibrio cholerae multiresistant to antibiotics.

Authors:  M Ouellette; G Gerbaud; P Courvalin
Journal:  Ann Inst Pasteur Microbiol       Date:  1988 Jan-Feb

6.  Incidence of Vibrio cholerae and related vibrios in a coastal lagoon and seawater influenced by lake discharges along an annual cycle.

Authors:  E Garay; A Arnau; C Amaro
Journal:  Appl Environ Microbiol       Date:  1985-08       Impact factor: 4.792

7.  Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay.

Authors:  J Kaper; H Lockman; R R Colwell; S W Joseph
Journal:  Appl Environ Microbiol       Date:  1979-01       Impact factor: 4.792

8.  A plasmid associated with virulence in the marine fish pathogen Vibrio anguillarum specifies an iron-sequestering system.

Authors:  J H Crosa
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

9.  Plasmid carriage in Vibrio vulnificus and other lactose-fermenting marine vibrios.

Authors:  L S Davidson; J D Oliver
Journal:  Appl Environ Microbiol       Date:  1986-07       Impact factor: 4.792

10.  Plasmid coding for drug resistance and production of heat-labile and heat-stable toxins harbored by an Escherichia coli strain of human origin.

Authors:  M L Silva; I C Scaletsky; M H Reis; M H Affonso; L R Trabulsi
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more
  8 in total

1.  Cloning and nucleotide sequence of a heat-stable enterotoxin gene from Vibrio cholerae non-O1 isolated from a patient with traveler's diarrhea.

Authors:  A Ogawa; J Kato; H Watanabe; B G Nair; T Takeda
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

2.  Surface and virulence properties of environmental Vibrio cholerae non-O1 from Albufera Lake (Valencia, Spain).

Authors:  C Amaro; A E Toranzo; E A González; J Blanco; M J Pujalte; R Aznar; E Garay
Journal:  Appl Environ Microbiol       Date:  1990-04       Impact factor: 4.792

3.  Phenotypic characterization of Vibrio vulnificus biotype 2, a lipopolysaccharide-based homogeneous O serogroup within Vibrio vulnificus.

Authors:  E G Biosca; J D Oliver; C Amaro
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

4.  Two defence systems eliminate plasmids from seventh pandemic Vibrio cholerae.

Authors:  Milena Jaskólska; David W Adams; Melanie Blokesch
Journal:  Nature       Date:  2022-04-06       Impact factor: 49.962

5.  Presence of a capsule in Vibrio vulnificus biotype 2 and its relationship to virulence for eels.

Authors:  E G Biosca; H Llorens; E Garay; C Amaro
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  Cell-surface charge and cell-surface hydrophobicity of collagen-binding Aeromonas and Vibrio strains.

Authors:  F Ascencio; G Johansson; T Wadström
Journal:  Arch Microbiol       Date:  1995-09       Impact factor: 2.552

7.  Molecular characterization and antibiotic susceptibility of Vibrio cholerae non-O1.

Authors:  A Dalsgaard; O Serichantalergs; C Pitarangsi; P Echeverria
Journal:  Epidemiol Infect       Date:  1995-02       Impact factor: 2.451

8.  Water sources as reservoirs of Vibrio cholerae O1 and non-O1 strains in Bepanda, Douala (Cameroon): relationship between isolation and physico-chemical factors.

Authors:  Jane-Francis Tatah Kihla Akoachere; Christelle Kwedjeu Pulcherie Mbuntcha
Journal:  BMC Infect Dis       Date:  2014-07-30       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.